Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. Ciprofloxacin/dexamethasone - Wikipedia

   en.wikipedia.org/wiki/Ciprofloxacin/dexamethasone

   Drug interactions have not been studied with Ciprodex. Commercialization. Ciprodex, owned by Alcon Laboratories, Inc., is protected by multiple patents and will be restricted from generic manufacturing until 2025. Ciprodex is the number 1 topical antibiotic ear drop prescribed since 2007 by ENTs and pediatricians.

3. Ciprofloxacin - Wikipedia

   en.wikipedia.org/wiki/Ciprofloxacin

   Ciprofloxacin is a fluoroquinolone antibiotic used to treat a number of bacterial infections. [5] This includes bone and joint infections, intra-abdominal infections, certain types of infectious diarrhea, respiratory tract infections, skin infections, typhoid fever, and urinary tract infections, among others. [5]

4. Colchicine - Wikipedia

   en.wikipedia.org/wiki/Colchicine

   Colchicine. Colchicine is a medication used to prevent and treat gout, [3] [4] to treat familial Mediterranean fever [5] and Behçet's disease, [6] and to reduce the risk of myocardial infarction. [7] The American College of Rheumatology recommends colchicine, nonsteroidal anti-inflammatory drugs (NSAIDs) or steroids in the treatment of gout.

5. Alcon - Wikipedia

   en.wikipedia.org/wiki/Alcon

   Alcon Inc. ( German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]

6. Diclofenac - Wikipedia

   en.wikipedia.org/wiki/Diclofenac

   Diclofenac (pronounced ⫽ daɪˈkloʊfənæk ⫽ [1] or ⫽ dɪklɒˈfɛnæk ⫽ [10] ), sold under the brand name Voltaren, among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammatory diseases such as gout. [7] It is taken by mouth or rectally in a suppository, used by injection, or applied to the skin.

7. US FDA approves expanded use of Sarepta's Duchenne gene ... - AOL

   www.aol.com/news/us-fda-approves-expanded...

   June 20, 2024 at 7:07 PM. By Leroy Leo and Sriparna Roy. (Reuters) -The U.S. Food and Drug Administration allowed the expanded use of Sarepta Therapeutics' gene therapy for patients with Duchenne ...